arrow
E

Eun-Jung Rhee

Sungkyunkwan University School of Medicine
H指数:65
被引数:1.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Efficacy and Safety of Pregabalin and Alpha-Lipoic Acid Combination in Patients With Painful Diabetic Peripheral Neuropathy: A Randomized, Open-Label, Non-Inferiority, Phase IV Clinical Trial and Subgroup Analysis (OPTIMUM Study)

奥普瑞巴林和α-硫辛酸联合治疗痛性糖尿病周围神经病变的疗效与安全性:一项随机、开放标签、非劣效性、IV期临床研究及亚组分析(OPTIMUM研究)

2026-04-290
OAAI
Research Code Sharing in Support of Gold Standard Science

支持黄金标准科学的代码共享研究

2026-01-140
PRE
Associations of Alcohol Consumption with All-Cause and Cancer Mortalities in Patients with Type 2 Diabetes Mellitus: A Nationwide Population Cohort Study

Lee DY,Moon SJ,Han KD,Ko JH,Jang HN,Kwon HM,等. 酒精摄入与2型糖尿病患者的全因死亡率和癌症死亡率的关系:一项全国性人群队列研究. 内分泌与代谢(韩国首尔). (2025) 14. doi: 10.3803/EnM.2024.2275

2025-12-011
OAAI
EffiCacy and safety of ANagliptin when added to iNsulin and metformin therapy in patients with uncontrolled type 2 diAbetes; randomized, placebo-controlled, double-blind, multicentre trial (CANNA study)

埃格利汀(ANagliptin)在胰岛素和二甲双胍疗法基础上添加治疗未控制2型糖尿病的疗效与安全性;随机、安慰剂对照、双盲、多中心试验(CANNA研究)

2025-06-250
OA
Metabolic Dysfunction-Associated Steatotic Liver Disease in Type 2 Diabetes Mellitus: A Review and Position Statement of the Fatty Liver Research Group of the Korean Diabetes Association

2型糖尿病中代谢功能障碍相关的脂肪变性肝病: 韩国糖尿病协会脂肪肝研究小组的回顾和立场声明

2024-11-300
PRE
Real-World Treatment Patterns according to Clinical Practice Guidelines in Patients with Type 2 Diabetes Mellitus and Established Cardiovascular Disease in Korea: Multicenter, Retrospective, Observational Study
2024-03-313
OAAI